Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy.

Al-Kadhimi, Zaid; Callahan, Michael; Fehniger, Todd; Cole, Kathryn E; Vose, Julie; Hinrichs, Steven

Al-Kadhimi, Zaid; Callahan, Michael; Fehniger, Todd; Cole, Kathryn E; Vose, Julie; Hinrichs, Steven.

Afiliação

Al-Kadhimi Z; Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, United States. Electronic address: zaid.alkadhimi@unmc.edu.
Callahan M; Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, United States.
Fehniger T; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States.
Cole KE; Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, United States.
Vose J; Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, United States.
Hinrichs S; Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, United States.

Int Immunopharmacol ; 113(Pt A): 109387, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36461582

Assuntos

Doença Enxerto-Hospedeiro; Leucemia; Humanos; Leucócitos Mononucleares; Imunoterapia Adotiva; Citocinas; Interleucina-12; Imunidade Inata; Receptores de Antígenos de Linfócitos T

Palavras-chave

Cell therapy; Cytokine; GVL; Innate immune cells; NK cell; Î³Î´ T-cells

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google